Gilbert’s is delighted to have contributed to the Chambers Life Sciences & Pharma IP Litigation 2024 Global Practice Guide. We were honoured to share our unique perspective on how and why life sciences and pharmaceuticals dominated IP litigation in Canada in 2023.
The Life Sciences & Pharma IP Litigation 2024 guide has expanded to 18 jurisdictions. The guide covers the latest developments in patent litigation, generic and biosimilar market entry, patent term extensions, available forms of relief, other IP rights, appeal, ADR and settlement/antitrust considerations.
The full guide can be accessed for free here.